Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) Stock Ticker

NASDAQ: IVVD · Healthcare · Biotechnology
$0.9342+2.29%
USD · as of 2026-09-28 · market cap $275.2M
Open IVVD in TickrDownload for iPhone

IVVD right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±27.5%
Options expect by Oct 29±56.9%
Priced in for Nov 5 earnings±63.2%
IV rank (30-day)74% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full IVVD picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on IVVD
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Invivyd, Inc.

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.

IVVD stock facts

Ticker symbolIVVD
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$275.2M
CEOMarc William Elia
Employees122
HeadquartersNew Haven, CT, US
IPO date2021-08-06
Websitewww.invivyd.com

What you can see for IVVD on Tickr

Live IVVD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the IVVD report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Invivyd, Inc.?

The ticker symbol for Invivyd, Inc. is IVVD, listed on the NASDAQ Global Market.

What is IVVD?

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management…

HomeExploreMarketLists
All pages